Galectin Therapeutics
GALT
Insider trades and stock quote 2024-2026
All insider trades at Galectin Therapeutics
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
7/14/2026
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$5.1 |
$83,285 |
|
6/29/2026
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$5.0 |
$239,234 |
|
6/29/2026
|
Sell |
Shlevin, Harold H. |
Director |
$5.0 |
$112,231 |
|
6/26/2026
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$5.0 |
$22,850 |
|
6/26/2026
|
Sell |
Shlevin, Harold H. |
Director |
$5.0 |
$38,660 |
|
6/23/2026
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$3.1 |
$23,729 |
|
5/26/2026
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$3.1 |
$1,761 |
|
2/6/2026
|
Buy |
Eldred, Kary |
Director |
$2.7 |
$810 |
|
1/6/2026
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$3.6 |
$78,205 |
|
1/6/2026
|
Sell |
Callicutt, Jack W. |
Chief Financial Officer |
$3.7 |
$74,695 |
|
1/6/2026
|
Sell |
Lewis, Joel |
President and CEO |
$3.6 |
$134,853 |
|
1/5/2026
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$3.9 |
$99,408 |
|
1/5/2026
|
Sell |
Callicutt, Jack W. |
Chief Financial Officer |
$3.9 |
$100,298 |
|
1/5/2026
|
Sell |
Lewis, Joel |
President and CEO |
$3.9 |
$108,342 |
|
1/2/2026
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$4.2 |
$54,789 |
|
1/2/2026
|
Sell |
Callicutt, Jack W. |
Chief Financial Officer |
$4.2 |
$58,394 |
|
1/2/2026
|
Sell |
Lewis, Joel |
President and CEO |
$4.2 |
$77,939 |
|
12/31/2025
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$4.1 |
$33,089 |
|
12/23/2025
|
Buy |
Eldred, Kary |
Director |
$3.7 |
$5,222 |
|
12/23/2025
|
Buy |
Freeman, Kevin D. |
Director |
$3.6 |
$58,542 |
|
12/17/2025
|
Sell |
Shlevin, Harold H. |
Director |
$7.0 |
$172,424 |
|
12/17/2025
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$7.0 |
$136,872 |
|
12/17/2025
|
Sell |
Lewis, Joel |
President and CEO |
$7.1 |
$55,241 |
|
12/16/2025
|
Sell |
10x Fund, L.p. |
Ten Percent Owner |
$6.7 |
$204,335 |
|
12/15/2025
|
Sell |
Shlevin, Harold H. |
Director |
$6.3 |
$53,027 |
|
12/12/2025
|
Sell |
Shlevin, Harold H. |
Director |
$6.3 |
$124,181 |
|
12/9/2025
|
Sell |
Shlevin, Harold H. |
Director |
$6.3 |
$105,206 |
|
12/8/2025
|
Sell |
Shlevin, Harold H. |
Director |
$6.0 |
$950,105 |
|
12/3/2025
|
Sell |
10x Fund, L.p. |
Ten Percent Owner |
$5.7 |
$1,444,355 |
|
12/2/2025
|
Sell |
10x Fund, L.p. |
Ten Percent Owner |
$5.5 |
$328,200 |
|
11/18/2025
|
Sell |
Callicutt, Jack W. |
Chief Financial Officer |
$6.2 |
$288,187 |
|
11/18/2025
|
Sell |
Lewis, Joel |
President and CEO |
$6.2 |
$41,723 |
|
11/17/2025
|
Sell |
Callicutt, Jack W. |
Chief Financial Officer |
$6.0 |
$190,663 |
|
11/17/2025
|
Sell |
Lewis, Joel |
President and CEO |
$6.0 |
$94,643 |
|
11/13/2025
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$5.5 |
$662,510 |
|
11/11/2025
|
Sell |
10x Fund, L.p. |
Ten Percent Owner |
$5.2 |
$210,000 |
|
11/10/2025
|
Sell |
Callicutt, Jack W. |
Chief Financial Officer |
$6.0 |
$31,884 |
|
11/10/2025
|
Sell |
Lewis, Joel |
President and CEO |
$6.0 |
$11,252 |
|
11/5/2025
|
Sell |
Callicutt, Jack W. |
Chief Financial Officer |
$6.0 |
$3,600 |
|
11/5/2025
|
Sell |
Lewis, Joel |
President and CEO |
$6.0 |
$1,200 |
|
11/4/2025
|
Sell |
Callicutt, Jack W. |
Chief Financial Officer |
$6.1 |
$173,778 |
|
11/4/2025
|
Sell |
Lewis, Joel |
President and CEO |
$6.1 |
$87,529 |
|
11/3/2025
|
Sell |
Callicutt, Jack W. |
Chief Financial Officer |
$6.0 |
$22,899 |
|
11/3/2025
|
Sell |
Lewis, Joel |
President and CEO |
$6.0 |
$7,813 |
|
10/22/2025
|
Sell |
10x Fund, L.p. |
Ten Percent Owner |
$4.9 |
$246,800 |
|
9/12/2025
|
Sell |
Lewis, Joel |
President and CEO |
$6.4 |
$89,048 |
|
9/12/2025
|
Sell |
Callicutt, Jack W. |
Chief Financial Officer |
$6.4 |
$56,054 |
|
7/21/2025
|
Buy |
Eldred, Kary |
Director |
$2.9 |
$2,925 |
|
7/17/2025
|
Buy |
Freeman, Kevin D. |
Director |
$2.9 |
$14,495 |
|
12/30/2024
|
Buy |
Shlevin, Harold H. |
Director |
$1.2 |
$7,540 |
|
12/24/2024
|
Buy |
Freeman, Kevin D. |
Director |
$0.8 |
$8,134 |
|
12/24/2024
|
Buy |
Eldred, Kary |
Director |
$0.8 |
$11,045 |
|
12/24/2024
|
Buy |
Zordani, Richard A. Jr. |
Director |
$0.8 |
$8,164 |
|
12/23/2024
|
Sell |
Callicutt, Jack W. |
Chief Financial Officer |
$0.9 |
$35,492 |
|
12/23/2024
|
Sell |
Lewis, Joel |
President and CEO |
$0.9 |
$49,610 |
|
12/23/2024
|
Sell |
Jamil, Khurram |
Chief Medical Officer |
$0.9 |
$12,044 |
|
10/23/2024
|
Buy |
Eldred, Kary |
Director |
$2.6 |
$1,300 |
|
10/17/2024
|
Buy |
Freeman, Kevin D. |
Director |
$2.6 |
$3,432 |
|
10/16/2024
|
Buy |
Freeman, Kevin D. |
Director |
$2.7 |
$27,000 |
|
8/23/2024
|
Buy |
Zordani, Richard A. Jr. |
Director |
$2.3 |
$6,346 |
|
8/22/2024
|
Buy |
Zordani, Richard A. Jr. |
Director |
$2.3 |
$1,704 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Free Updates via Email
Please confirm your email address